Latent Autoimmune Diabetes in Adults (LADA): From Immunopathogenesis to Immunotherapy.
Hu J, Zhang R, Zou H, Xie L, Zhou Z, Xiao Y.
Front Endocrinol (Lausanne). 2022 Jul 21;13:917169. doi: 10.3389/fendo.2022.917169. eCollection 2022.
Editorial: Latent Autoimmune Diabetes in Adults (LADA).
Leslie RD.
Front Endocrinol (Lausanne). 2022 Aug 29;13:1002776. doi: 10.3389/fendo.2022.1002776. eCollection 2022.
Latent autoimmune diabetes in adults (LADA) in Asian and European populations.
Kumar A, de Leiva A.
Diabetes Metab Res Rev. 2017 Jul;33(5). doi: 10.1002/dmrr.2890. Epub 2017 Mar 16.
Anti-Islet Autoantibodies in Type 1 Diabetes.
Kawasaki E.
Int J Mol Sci. 2023 Jun 11;24(12):10012. doi: 10.3390/ijms241210012.
Latent autoimmune diabetes in the adults (LADA) in Asia: from pathogenesis and epidemiology to therapy.
Guglielmi C, Palermo A, Pozzilli P.
Diabetes Metab Res Rev. 2012 Dec;28 Suppl 2:40-6. doi: 10.1002/dmrr.2345.
Interventions for latent autoimmune diabetes (LADA) in adults.
Brophy S, Brunt H, Davies H, Mannan S, Williams R.
Cochrane Database Syst Rev. 2007 Jul 18;(3):CD006165. doi: 10.1002/14651858.CD006165.pub2.
Prevalence and factors associated with latent autoimmune diabetes in adults (LADA): a cross-sectional study.
Manisha AM, Shangali AR, Mfinanga SG, Mbugi EV.
BMC Endocr Disord. 2022 Jul 8;22(1):175. doi: 10.1186/s12902-022-01089-1.
LADA: A Type of Diabetes in its Own Right?
Grill V.
Curr Diabetes Rev. 2019;15(3):174-177. doi: 10.2174/1573399814666180716150905.
Latent autoimmune diabetes in adults (LADA) should be less latent.
Fourlanos S, Dotta F, Greenbaum CJ, Palmer JP, Rolandsson O, Colman PG, Harrison LC.
Diabetologia. 2005 Nov;48(11):2206-12. doi: 10.1007/s00125-005-1960-7. Epub 2005 Sep 29.
Latent autoimmune diabetes in adults in China.
Qiu J, Xiao Z, Zhang Z, Luo S, Zhou Z.
Front Immunol. 2022 Aug 25;13:977413. doi: 10.3389/fimmu.2022.977413. eCollection 2022.
